More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

Mayne Pharma launches Amiodarone 100mg tablets

Jan 12, 2017 at 9:50 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Jan 12, 2017 at 9:50 PM EST

On 6ix: 6ix.com/news/mayne-pharma-launches-amiodarone-100mg-tablets

Watch Mayne Pharma's latest call↗Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call↗

Mayne Pharma Group Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Mayne Pharma Group Ltd. on 6ix

Earlier from Mayne Pharma

  • Mayne Pharma launches Fabior and Sorilux in the USJan 10, 2017
  • Update on Status of DOJ InvestigationDec 15, 2016
  • S&P DJ Indices Announces March Quarterly RebalanceNov 7, 2016
  • MYX launches generic MS Contin (morphine sulfate) tabletsNov 2, 2016
  • IDT: 1st generic proprietary prod shipped to US, temozolomideNov 1, 2016

Later from Mayne Pharma

  • Mayne Pharma launches Butalbital / APAP tablets in the USFeb 15, 2017
  • 2017 Half Year Media ReleaseFeb 23, 2017
  • License and supply agreement for generic Nuvaring in the USFeb 27, 2017
  • Mayne Pharma acquires rights to generic Duragesic in the USMar 8, 2017
  • Clarification statementMay 2, 2017
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer